- Home
- EYEN vs PETS Comparison
EYEN vs PETS Comparison
Compare EYEN & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- PETS
- Stock Information
- Founded
- EYEN 2014
- PETS 1996
- Country
- EYEN United States
- PETS United States
- Employees
- EYEN N/A
- PETS N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- EYEN Health Care
- PETS Consumer Staples
- Exchange
- EYEN Nasdaq
- PETS Nasdaq
- Market Cap
- EYEN 38.2M
- PETS 82.0M
- IPO Year
- EYEN 2018
- PETS N/A
- Fundamental
- Price
- EYEN $0.55
- PETS $4.07
- Analyst Decision
- EYEN Strong Buy
- PETS Sell
- Analyst Count
- EYEN 2
- PETS 2
- Target Price
- EYEN $12.00
- PETS $3.50
- AVG Volume (30 Days)
- EYEN 879.0K
- PETS 182.6K
- Earning Date
- EYEN 11-11-2024
- PETS 11-06-2024
- Dividend Yield
- EYEN N/A
- PETS 29.41%
- EPS Growth
- EYEN N/A
- PETS N/A
- EPS
- EYEN N/A
- PETS N/A
- Revenue
- EYEN $31,405.00
- PETS $270,772,000.00
- Revenue This Year
- EYEN $50,309.30
- PETS N/A
- Revenue Next Year
- EYEN $421.63
- PETS $3.27
- P/E Ratio
- EYEN N/A
- PETS N/A
- Revenue Growth
- EYEN N/A
- PETS 2.26
- 52 Week Low
- EYEN $0.37
- PETS $2.90
- 52 Week High
- EYEN $2.57
- PETS $8.27
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- PETS 56.76
- Support Level
- EYEN $0.52
- PETS $3.78
- Resistance Level
- EYEN $0.59
- PETS $4.17
- Average True Range (ATR)
- EYEN 0.05
- PETS 0.18
- MACD
- EYEN 0.01
- PETS -0.01
- Stochastic Oscillator
- EYEN 66.45
- PETS 62.22
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.